The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage

被引:13
|
作者
White, C. Roger [1 ]
Datta, Geeta [1 ]
Wilson, Landon [3 ]
Palgunachari, Mayakonda N. [1 ]
Anantharamaiah, G. M. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
ApoA-I; ApoA-I mimetic peptide; Hypochlorous acid; Oxidation; Cholesterol efflux; HIGH-DENSITY-LIPOPROTEIN; CORONARY ATHEROSCLEROSIS; HDL; NANOPARTICLES; CHOLESTEROL; DISEASE; MILANO;
D O I
10.1016/j.chemphyslip.2019.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [21] An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration
    Chen, Xun
    Burton, Charlotte
    Song, Xuelei
    Mcnamara, Lesley
    Langella, Annunziata
    Cianetti, Simona
    Chang, Ching H.
    Wang, Jun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (05): : 489 - 499
  • [22] Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats
    Zhang, Zhenghao
    Datta, Geeta
    Zhang, Yun
    Miller, Andrew P.
    Mochon, Paulina
    Chen, Yiu-Fai
    Chatham, John
    Anantharamaiah, G. M.
    White, C. Roger
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (02): : H866 - H873
  • [23] The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro
    Tabet, Fatiha
    Remaley, Alan T.
    Segaliny, Aude I.
    Millet, Jonathan
    Yan, Ling
    Nakhla, Shirley
    Barter, Philip J.
    Rye, Kerry-Anne
    Lambert, Gilles
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 246 - U223
  • [24] Cloning and expression analysis of apolipoprotein A-I (ApoA-I) in the Hong Kong grouper (Epinephelus akaara)
    Qu, Meng
    Huang, Xiaohong
    Zhang, Xiaojie
    Liu, Qiaohong
    Ding, Shaoxiong
    AQUACULTURE, 2014, 432 : 85 - 96
  • [25] Apolipoprotein A-I Mimetic Peptide D-4F Reduces Cardiac Hypertrophy and Improves Apolipoprotein A-I Mediated Reverse Cholesterol Transport From Cardiac Tissue in LDL Receptor-null Mice Fed a Western Diet
    Han, Jie
    Zhang, Song
    Ye, Ping
    Liu, Yong-Xue
    Qin, Yan-wen
    Miao, Dong-Mei
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (05) : 412 - 417
  • [26] ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling
    Rudolf, Martin
    Sefat, Armin Mir Mohi
    Miura, Yoko
    Tura, Aysegul
    Raasch, Walter
    Ranjbar, Mahdy
    Grisanti, Salvatore
    Aherrahrou, Zouhair
    Wagner, Anna
    Messinger, Jeffrey D.
    Garber, David W.
    Anantharamaiah, G. M.
    Curcio, Christine A.
    CURRENT EYE RESEARCH, 2018, 43 (01) : 135 - 146
  • [27] Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis
    Li, Yuanyuan
    Xu, Yanyong
    Jadhav, Kavita
    Zhu, Yingdong
    Yin, Liya
    Zhang, Yanqiao
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (08) : 1574 - 1587
  • [28] PPAR Represses Apolipoprotein A-I Gene but Impedes TNF-Mediated ApoA-I Downregulation in HepG2 Cells
    Shavva, Vladimir S.
    Mogilenko, Denis A.
    Bogomolova, Alexandra M.
    Nikitin, Artemy A.
    Dizhe, Ella B.
    Efremov, Alexander M.
    Oleinikova, Galina N.
    Perevozchikov, Andrej P.
    Orlov, Sergey V.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (09) : 2010 - 2022
  • [29] Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo
    Shimizu, Tomohiko
    Tanigawa, Hiroyuki
    Miura, Shin-ichiro
    Kuwano, Takashi
    Takata, Kohei
    Suematsu, Yasunori
    Imaizumi, Satoshi
    Yahiro, Eiji
    Zhang, Bo
    Uehara, Yoshinari
    Saku, Keijiro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 192 : 82 - 88
  • [30] ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice
    Wang, Xiaohui
    Li, Rongwen
    Zacharek, Alex
    Landschoot-Ward, Julie
    Chopp, Michael
    Chen, Jieli
    Cui, Xu
    FRONTIERS IN NEUROSCIENCE, 2019, 13